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Abstract
Background: Instruments for field diagnosis of eczema are increasingly used, and it is essential to understand
specific limitations to make best use of their strengths. Our objective was to assess the validity of ISAAC and UK
Working Party criteria for field diagnosis of eczema in children.
Methods: We performed a cohort study in urban Brazil. Parents/guardians of 1,419 children answered ISAAC phase
II questionnaire. Children were examined for skin lesions (UKWP protocol). Two dermatologists examined most
cases of eczema (according to ISAAC or UKWP), and a sample without eczema.
Results: Agreement between repeat questionnaires on the filter question was poor (kappa = 0.4). Agreement
between the 2 dermatologists was fair (kappa = 0.6). False positive reports included scabies in 39% of ISAAC cases
and 33% of UKWP cases. Sensitivity and PPV were low (ISAAC: 37.1% and 16.1%; UKWP: 28.6% and 23.8%).
Specificity and NPV were high (ISAAC: 90.0% and 96.6%; UKWP: 95.3% and 96.2%). One-year prevalence of eczema
was 11.3% (ISAAC), 5.9% (UKWP) and 4.9% (adjusted dermatologist diagnosis). Point prevalence of scabies (alone or
not) was 43%, 33% and 18%, in eczemas according to ISAAC, to UKWP and to dermatologists. The reasons why
children with eczema were not identified by ISAAC or UKWP were wrongly denying dry skin, itchy rash or personal
history of atopic diseases. A limitation is that questionnaire was already validated in Brazil, but not field tested in
this specific setting.
Conclusions: Studies using UKWP or ISAAC criteria should include a validation arm, to contribute to the
understanding of potential limitations of their use in different contexts and to explore solutions. We list specific
recommendations.
Background
Eczema has recently been proposed by the World
Allergy Organization [1] to replace terms such as atopic
dermatitis, atopic eczema, atopic eczema/dermatitis syn-
drome, previously used interchangeably in the literature
[2]. Its individual diagnosis is a relatively undisputed
matter: a chronic, or chronically relapsing, inflammatory
skin disease, characterized by itchy papules, which
become excoriated and lichenified, whose distribution
pattern changes during lifetime from more generalized
eruptions with oozing and crusted lesions in early child-
hood, to the childhood pattern of typical flexural eczema
with lichenification and a scaly, xerotic, uninvolved skin,
to the adult distribution pattern, essentially similar to
that in later childhood [3]. However, the complexities of
the clinical aspects of eczema, even after the pioneer
effort by Hanifin and Rajka to organize them in a set of
diagnostic elements [4], make them unsuitable for use
in population-based studies. Other groups set more
recently about establishing standardized criteria for
eczema diagnosis in population settings [5-7]. Some ele-
ments of the protocol proposed by Williams et al (the
so called UK Working Party (UKWP) criteria), which
combines a standardized questionnaire and a set of
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reference photographs, were incorporated in the instru-
ment (a questionnaire) adopted by the International
Study of Asthma and Allergies in Childhood (ISAAC)
[8] in its surveys.
Validation studies of ISAAC and UKWP criteria,
mostly conducted in children and young subjects, found
variable results [9-22]. Some studies, mainly carried out
in developed countries, found high sensitivity and speci-
ficity [9,10,14,16-18,22], whereas others, mainly in low
and middle income countries, found middle to low sen-
sitivity and high specificity [11-13,15,19,20]. Two recent
studies in adults, both in a developed country, found
middle to low sensitivity and high specificity [23,24].
The reasons behind the variations are not clear, but the
following suggestions have been put forward: intermit-
tent nature of eczema [22], mild forms of eczema in the
community (compared to those in hospitals or clinics),
high prevalence of scabies (compared to the prevalence
of eczema) [20], recall bias [24], language misunder-
standing or cultural specificities [12,15,19,22], in particu-
lar denial of itching from parents [14,20], leading to
false negative diagnosis. A recent review lists eight
groups of possible reasons for the variation in validity:
differences in study characteristics, different reference
standards, different periods of prevalence to establish
the diagnosis of eczema, high prevalence of scabies,
exclusion of “visible flexural dermatitis” from the cri-
teria, translation and cultural issues (such as the inter-
pretation of pruritus), low prevalence of eczema and
different methodological strengths [25].
This study aimed to validate the ISAAC and UKWP
coding of the UKWP-ISAAC questionnaire for eczema
in an urban setting of a middle developed country.
Methods
This study represents the eczema arm of a cohort study
conducted in the city of Salvador, Brazil, to study aller-
gic diseases. The design of the original study is pre-
sented in detail elsewhere [26]. The methods relevant
for this analysis are presented below.
The study population consisted of 1,419 children.
Their parent\guardians answered the ISAAC phase II
core questionnaire for eczema [24], translated into Por-
tuguese and back-translated into English, and validated
[18]. The relevant questions are presented in Figure 1.
The children were also examined for skin lesions
according to the UKWP protocol. Because of the over-
lap between slightly different filter questions in ISAAC
and UKWP questionnaires, we used only the ISAAC
version so that the first two questions of the ISAAC
core questionnaire ("Has your child ever had an itchy
rash that came and went for at least 6 months?” and
“Has your child had this itchy rash at any time in the
last 12 months?”) were used as filter questions for the
UKWP protocol too, in place of the original one (“Has
your child had an itchy skin condition in the last
12 months?”). So we departed from the recommended
UKWP protocol only in that we included in the screen-
ing questions a requirement for the itchy lesion to come
and go for at least 6 months rather than just having
been present.
Two trained observers examined the children and
applied the questionnaire. The observers, two health
operators with auxiliary nurse training, spent some ses-
sions in an outpatient clinic with a dermatologist, who
introduced them to the types of basic skin lesions and
showed them children with different skin problems
including eczema, briefly commenting the characteris-
tics of the lesions (aspect, site and history). Besides
seeing patients, the observers were trained to recognize
the flexural dermatitis through the use of the UKWP
photographic protocol and training photographs set.
All children, not only those with a report of recurrent
itchy skin lesions, were examined. Results of the physi-
cal examination were noted in terms of whether there
was a skin lesion, what type, in what body area, and
whether it was consistent with any of the 20 UKWP
photographs.
Data from the questionnaire were coded by one of the
authors (AS). Cases were defined based on two coding
systems:
1) ISAAC criteria (positive responses to the questions
1 to 3 of the core questionnaire of eczema, Figure 1)
[27];
2) UKWP criteria (positive response to question 2,
plus three or more of the following supplementary ele-
ments: history of flexural involvement (question 3),
onset below 2 years of age (question 4), history of gen-
erally dry skin (question 8), personal history of other
atopic disease, and visible flexural dermatitis as per
photographic protocol) [24]. The history of other atopic
diseases was based on questions from the ISAAC’s core
questionnaires of wheezing and rhinitis, Figure 1, i.e., a
positive response to any question from 1 to 3 or a posi-
tive response to question 4 plus reported use of antihis-
taminic drugs and/or topic corticosteroids. The field
workers, the parent/caretakers and the dermatologists
remained blind to the classification.
For operational reasons, the questionnaires were
applied twice to about half the children (736); these
were used to estimate repeatability. Data were collected
between September 2005 and March 2006.
A sample of children was independently seen by 2
dermatologists for validation. Children were selected for
referral based on their answers to the ISAAC question-
naire (for children interviewed twice, the second ques-
tionnaire was used). Children were classified in three
groups, with different sampling frames for referral. The
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Figure 1 Field Questionnaire.
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first group consisted of children with eczema according
to either ISAAC or UKWP. The second group consisted
of children without eczema according to ISAAC or
UKWP, but with a positive response to the question:
“Has your child had this itchy rash that came and went
at any time in the past 12 months?”. The third group
consisted of children without eczema or itchy rash. The
proportions selected for validation in each group were
roughly: 100% of the first group, half of the second
group, and one in twenty of the third group.
The proportions seen by the dermatologists in each
group are presented in Table 1. The dermatologists,
both of which were consultant dermatologists, con-
ducted independently a clinical consultation to establish
if the child had eczema based on history and clinical
examination, and prepared a standard report that
included whether in their opinion the child had eczema
(as eczema, possible eczema and no eczema) and any
alternative diagnosis.
For the children with repeated questionnaires we
investigated agreement between first and second ques-
tionnaires for the filter question ("Has your child ever
had an itchy rash that came and went for at least
6 months?”), and for the diagnosis of eczema using
UKWP and ISAAC criteria separately, according to
whether they had the same respondent and the same
observer.
After examining the consistency between the two der-
matologists, children classified by them as possible ecze-
mas were grouped with those classified as non eczema.
Agreement between the diagnoses of the two dermatolo-
gists was assessed by contingency tables and kappa
statistics.
To examine the reasons for disagreement between the
diagnosis based on the questionnaire and made by
the dermatologists, we considered as the gold standard
for eczema a diagnosis of eczema by at least one
dermatologist. The dermatologists’ diagnoses for false
positives were listed and the reasons for false negatives
were investigated.
Due to different fractions having been sampled for
referral from each of the groups (children with eczema,
without eczema but with an itchy rash, and without
eczema or itchy rash), the prevalence of eczema PR was
independently calculated, for each of the two field defini-
tions of eczema, on the original population weighted by
the inverse of the sampling fraction of each group (Table
1), according to the formula PR = (E(dr)Gr1*WGr1 + E(dr)
Gr2*WGr2 + E(dr)Gr3*WGr3)/Pop*100, where E(dr) is the
number of eczemas diagnosed by the dermatologists in a
group and W its weighting, and Pop is the total popula-
tion investigated.
Using dermatologist diagnosis as a gold standard, sen-
sitivity, specificity, positive predictive value (PPV) and
negative predictive value (NPV) were estimated sepa-
rately for ISAAC and UKWP coding. To estimate the
potential improvement in UKWP validity if photographs
had been more widely used, we recalculated sensitivity,
specificity, PPV and NPV if the 8 false negative cases
had had a positive photo identification.
Contingency tables, sensitivity, specificity, PPV, NPV
and kappa statistics were calculated with Stata (ver.9.0).
Ethical approval was obtained from the LSHTM and
from the UFBA ethical committee. A written informed
consent was obtained from the parents of the children
involved.
Results
Of the 1,445 eligible children, 1,419 (758 boys), aged
between 4 and 12 (median 7, IQR 6-9) years, completed
the questionnaire and were included in the study.
The median interval between first and second ques-
tionnaire was 4.4 months. The agreement between the
first and the second questionnaires for the filter ques-
tion ("have you ever had an itchy rash...”) was poor
(kappa = 0.33) for all the pairs, and only slightly better
for the pairs with the same respondent, and those with
the same respondent and observer (Table 2). This was
mainly because of the high proportion of positive
answers in the first questionnaire that were negative in
the second questionnaire (53%). This was very margin-
ally better when the respondent was the same (48%) and
the respondent and observer were the same (47%)
The agreement between the first and the second ques-
tionnaires on presence of eczema was poor for all pairs
(kappa = 0.34, when coded using ISAAC, and kappa =
0.29, using UKWP). When kappa was calculated sepa-
rately for pairs with the same respondent and the same
respondent and observer, there was a slight improve-
ment for ISAAC coding, and a more marked improve-
ment for UKWP coding. Once again, the poor
Table 1 Children seen in the field and visited by the
dermatologists
seen in
the
field
seen by
dermatologists
sampling
fraction
(SF)
weighting
(1/SF)
ISAAC+ 161 150 93.2% 1.07
ISAAC-
scratchers+
51 25 49.0% 2.04
ISAAC-
scratchers-
1207 58 4.8% 20.81
UKWP+ 84 78 92.9% 1.08
UKWP-
scratchers+
128 97 75.8% 1.32
UKWP-
scratchers-
1207 58 4.8% 20.81
“scratcher’ by filter question: “Has your child had this itchy rash that came
and went at any time in the past 12 months?”
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agreement was mainly attributable to the high propor-
tion of children classified as having eczemas in the first
questionnaire that were not classified as eczema in the
second questionnaire (64% for ISAAC coding, and 74%
for UKWP coding). These proportions were smaller, but
still over half, when the respondent was the same (56%
for ISAAC and 61% for UKWP) and when the respon-
dent and the observer were the same (58% for ISAAC
and 63% for UKWP) (Table 3).
Of the 233 children referred to the dermatologists,
212 were seen by both dermatologists. The median time
between field and validation was 8 days (IQ range
6-21.5 days) Agreement between dermatologists was
fairly good for non-eczemas (89.8% and 88.8% of non-
eczemas according to one dermatologist were non-
eczemas for the other one). Agreement was less good
for eczema diagnosis (63.2% and 62.3% of eczemas
according to one dermatologist were eczemas for the
other one), and was very poor for the diagnosis of pos-
sible eczema, most of which (82.4% and 86.7%) were
not eczemas for the other dermatologist (Table 4). We
decided, therefore, to group non-eczemas and possible
eczemas in the same category for each dermatologist.
After this, the kappa for concordance between the two
dermatologists was 0.56.
We examined the reports for children with a false
positive field diagnosis (129 children by ISAAC and 59
by UKWP). Each child had a maximum of two reports,
one from each dermatologist. The proportions of
ISAAC false positives reports and UKWP false positives
reports that included scabies were 39% and 33%, respec-
tively, that included prurigo were 12% (ISAAC) and 15%
(UKWP) and with no dermatologic alteration were 10%
(ISAAC) and 13% (UKWP). Other diagnoses were pre-
sent in smaller numbers (Table 5).
Table 6 shows the proportion of children who had a
diagnosis of scabies (alone or in combination with
another diagnosis) by at least one of the dermatologists,
separately for ISAAC and UKWP coding, in each of six
categories, i.e., two of dermatologist diagnosis of eczema
Table 2 Consistency between 1st and 2nd questionnaire
to the ISAAC filter question1
all the pairs same
respondent
same
respondent
and same
observer
1st questionnaire 2nd
questionnaire
2nd
questionnaire
2nd
questionnaire
yes no Total yes no Total yes no Total
yes 97 108 205 78 71 149 46 41 87
no 70 367 437 49 267 316 27 130 157
Total 167 475 642 127 338 465 73 171 244
kappa = 0.33
95% CI 0.25-0.41
kappa = 0.38
95% CI 0.29-0.47
kappa = 0.37
95% CI 0.25-0.49
1“Has your child ever had an itchy rash that came and went for at least 6
months?”
Table 3 Consistency of diagnosis of eczema between 1st
and 2nd questionnaire
all pairs same
respondent
same
respondent
and same
observer
ISAAC coding
1st questionnaire
2nd
questionnaire
2nd
questionnaire
2nd
questionnaire
Yes No Total Yes No Total Yes No Total
Yes 33 58 91 28 35 63 14 19 33
No 34 515 549 27 373 400 14 195 209
Total 67 573 640 55 408 463 28 214 242
kappa = 0.34
95% CI 0.26-0.41
kappa = 0.40
95% CI 0.31-0.49
kappa = 0.38
95% CI 0.26-0.51
UKWP coding
1st questionnaire
2nd
questionnaire
2nd
questionnaire
2nd
questionnaire
Yes No Total Yes No Total Yes No Total
Yes 12 28 40 12 19 31 7 12 209
No 21 579 600 13 419 431 4 219 33
Total 33 607 640 25 438 463 11 231 242
kappa = 0.29
95% CI 0.21-0.37
kappa = 0.39
95% CI 0.30-0.48
kappa = 0.43
95% CI 0.31-0.56
Table 4 Consistency of diagnosis between the 2
dermatologists
2nd dermatologist’s diagnosis
1st dermatologist’s diagnosis eczema + possible
eczema
eczema - Total
eczema + 12 1 6 19
possible eczema 2 1 14 17
eczema - 5 13 158 176
Total 19 151 171 212
kappa = 0.56 (95% CI 0.46-0.73), with negative and possible cases collapsed
together
Table 5 Dermatologists’ diagnoses for children with
eczema according to ISAAC or UK Working Party, but not
according to dermatologists
ISAAC
eczemas
(N = 126)
UKWP
eczemas
(N = 59)
Scabies 39.0% 33.3%
prurigo (strophulus) 11.6% 14.9%
no dermatologic alteration 10.4% 13.2%
miliaria (prickly heat) 5.4% 7.0%
residual hypercromic macules 4.1% 3.5%
pityriasis alba 3.7% 3.5%
xerodermia 2.5% 5.3%
tinea corporis 2.5% 3.5%
dyshidrotic eczema 2.5% 2.6%
others 18.3% 13.2%
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by three of field assessment (eczema and non-eczema
with or without an itchy rash). The prevalence of sca-
bies, as diagnosed by dermatologists, was high (36%).
Among children with no reported itching in the ques-
tionnaire, 19% had a diagnosis of scabies. The propor-
tion with scabies was higher in children with a diagnosis
of eczema according to ISAAC (43%) than in those diag-
nosed with eczema according to UKWP (33%). Only
18% of the children diagnosed as eczema by the derma-
tologists had scabies.
When dermatologists diagnosed eczema in children
coded as non-eczema by ISAAC or UKWP, the reasons
for the disagreement were: the caretaker denied the
child suffered from dry skin in the last 12 months but
the dermatologist found dry skin (in 1 non-eczema
according to ISAAC and 5 according to UKWP); the
caretaker denied the presence of an itchy rash (ever or
in the past 12 months), but the dermatologist elicited its
presence in the child’s history (in 2 non-eczemas
according to both ISAAC and UKWP); the caretaker
denied the personal history of asthma/rhinitis, but the
dermatologist elicited such a history, in 1 non-eczema
according to UKWP. Four of the 8 false negatives
according to UKWP would have been coded as eczema
if they had had a positive photograph identification.
The prevalence estimated using the questionnaire is
very different when coded to ISAAC (11.3%) and to
UKWP (5.9%). Applying the weights from the sampling
fractions from Table 1 to the dermatologist diagnosis,
the estimated true prevalence of eczema in the original
population (using either ISAAC or UKWP) was 4.9%.
We estimated the validity of each coding scheme using
the dermatologist diagnosis as the gold standard, and
using the weights from the sampling fraction. The sensi-
tivity, specificity, PPV and NPV were, for ISAAC, 37.1%,
90.0%, 16.1% and 96.6%, respectively, and, for UKWP,
28.6%, 95.3%, 23.8% and 96.2%, respectively. The UKWP
sensitivity and PPV would have been a little higher if
the false positives had had a positive photograph identi-
fication (35.7% and 28.4%), but the specificity and NPV
would have been very similar (96.0% and 96.6%). The
agreement between dermatologists diagnosis and ISAAC
field diagnosis was very low (kappa = 0.09), and between
dermatologists and UKWP field diagnosis was low
(kappa = 0.23).
At the physical examination by the field workers,
1,142 children overall had skin lesions, 433 had lesions
in flexural sites, 217 had lesions compatible with eczema
following the UKWP criteria (scaling, vesicles, crusts or
lichenification, whether or not associated with erythema)
[28], and 105 had lesions compatible with eczema in a
flexural area. Only 32 children had lesions that were
linked to a photograph in the UKWP protocol.
Of the 105 children who presented lesions compatible
with dermatitis in a flexural area, only 13 were classified
as eczema by the UKWP criteria. Of the 92 that were
not, 66 replied no to the first filter question ("Has your
child ever had an itchy rash that came and went for at
least 6 months?”) and an additional 9 no to the second
filter question ("Has your child had this itchy rash at
any time in the last 12 months?”). As for the 17 left, the
carer referred for most of them a history of itchy lesions
in flexural sites in the past 12 months, but very rarely a
history of dry skin or a personal history of other atopic
diseases, and the field worker did not associate any
photo of the UKWP protocol. Of the 105 children with
lesions compatible with dermatitis in a flexural area, 31
were seen by the dermatologists for validation. Of the
31 children, 12 had eczema according the UKWP cri-
teria. Of these 12, 1 was diagnosed by the dermatolo-
gists as having eczema, 6 as having scabies, and the
other 5 with a range of other diagnoses, including mili-
aria and prurigo.
Discussion
In this validation study, UKWP coding was as good as
ISAAC on specificity and NPV, and better, but still not
very good, on sensitivity and PPV. Agreement between
first and second questionnaire was not good, even when
observer and respondent were the same. False positives
were mostly attributable to scabies (mostly for ISAAC
coded questionnaires) but since specificity was high, this
was not the main problem. False negatives were mostly
caused by respondents denying itch, dry skin or a his-
tory of allergic diseases when those features were identi-
fied by the dermatologists on their validation. Although
observers identified and described lesions in the major-
ity of the children, they were very reluctant to link
lesions to photographs. Had the false negatives been
linked to a photograph, given the scoring scheme, half
Table 6 Frequency of scabies diagnosis (made by any
dermatologist)1, by field assessment and dermatologist’s
diagnosis of eczema
Dermatologists’ diagnosis
Eczema+ eczema- Total
ISAAC
eczema+ 24 5 20.8% 126 59 46.8% 150 64 42.7%
eczema-/scratcher+ 1 0 0.0% 24 8 33.3% 25 8 32.0%
eczema-/scratcher- 2 0 0.0% 56 11 19.6% 58 11 19.0%
UKWP
eczema+ 19 2 10.5% 59 24 40.7% 78 26 33.3%
eczema-/scratcher+ 6 3 50.0% 91 43 47.3% 97 46 46.4%
eczema-/scratcher- 2 0 0.0% 56 11 19.6% 58 11 19.0%
Total 27 5 18.5% 206 78 37.9% 233 83 35.6%
1Number and percentage of scabies diagnosis in italic
’scratcher’ by filter question: “Has your child had this itchy rash that came and
went at any time in the past 12 months?”
Strina et al. BMC Dermatology 2010, 10:11
http://www.biomedcentral.com/1471-5945/10/11
Page 6 of 9
would have been considered eczema according to
UKWP coding scheme. Recognition of a lesion compati-
ble with eczema in a flexural site was rarely associated
with UKWP diagnosis or with an eczema diagnosis by
the dermatologists. Prevalence estimated by UKWP was
quite accurate and very similar to that estimated based
on doctors diagnosis, in spite of the low sensitivity. This
was due to the fact that there were similar number of
false positives and false negatives in the population. The
ISAAC’s prevalence estimate performed far less accu-
rately, thus probably challenging, at least in this particu-
lar setting, its validity at the population level [29]. So in
summary UKWP was better than ISAAC coding, but
sensitivity was still low, although estimates of prevalence
were accurate and specificity high.
The study had some limitations. The use of a more
restrictive filter question than the usual UKWP criteria
to allow evaluation of the ISAAC criteria could have
potentially contributed to the low sensitivity. The use of
this question was evaluated in the UK [7] and in that
context did not lower sensitivity. However this is likely
to be different in our setting where the low concordance
for this question in the repeat sample suggests that this
question was not well understood. This is particularly
relevant because we did not field test the questionnaire
in our setting, as it had been validated in Brazil earlier
[18], nor did we use qualitative studies to investigate the
social acceptability of reporting itching.
The observers linked lesions to the UKWP photos in
very few children. We did not test the observers for-
mally for their use of the photographs before going to
the field. Had we done that, we might have extended
their already substantial training,
In places where other skin diseases like scabies are
common, the value of flexural dermatitis as diagnosis of
eczema is limited. We suggest that it may be important
to consider ways of dealing with scabies (maybe using
response to treatment as a diagnostic test). This will be
further complicated by the fact that in populations with
high prevalence of scabies, people with eczema will also
have scabies. Improved recognition of scabies however
will improve specificity, not sensitivity.
The difficulty of identifying eczema during remission
is well established. This might complicate validation
studies if the dermatologists do not examine the chil-
dren at the same time as the field observers. This is
unlikely to have contributed to the disagreement
between field diagnosis and the dermatologist, as the
median time between field and validation was 8 days.
Another potential limitation of validations is difference
in duration of the period considered, for example
when prevalence is measured over a 12 month period
in the instruments and over a point in time by the der-
matologists. In our study this was mitigated by the fact
that the dermatologists were considering the long term
diagnosis as they would in their clinical practice, based
on history and examination,
Finally, the age of the study population was one where
eczema prevalence is usually low. The children in our
study were all aged over 4, and some were as old as 12.
This is likely to be a problem when the ISAAC ques-
tionnaire is applied mostly to study asthma, and the
eczema questionnaire used as a secondary objective. It is
because of low prevalence that PPV is low in spite of
the high specificity and NPV is high in spite of the low
sensitivity. This is one more reason why validity esti-
mated in hospital cases is not generalizable to situations
when questionnaires are applied to a general population.
As a consequence of the very low PPV most cases diag-
nosed in the field questionnaire are not eczema (are
false positives) and therefore are not suitable for studies
of causality.
Many of our findings are similar to previous validation
studies, where the specificity of UKWP tended to be
high, although the sensitivity was very varied. Low sensi-
tivity in previous studies has been attributed to similar
reasons as in our study.
Conclusions
UKWP was better than ISAAC and less affected by sca-
bies. Both had good specificity and low sensitivity, and
UKWP was very accurate in estimating prevalence
although this was based on similar numbers of false
negative and false positive cases.
Our recommendations for studies of eczema using
field instruments are that
1. Studies conducted in a new setting should field test
the instrument even when it has been previously vali-
dated in another setting in the same country. The field
test must aim to arrive at a form of word such that
questions are clearly understood by the population, as
denial in the questionnaire of the filter questions and of
itching, dry skin and family history are behind the low
sensitivity. It might be necessary to study whether there
are cultural barriers to acknowledging itching.
2. Keep in mind that validity obtained using hospital
cases may overestimate validity in the population.
3. Studies in which UKWP photographic protocol is
employed always test the trained personnel in the use of
photographs.
4. Where other itchy eczematous looking skin diseases
(such as scabies) are common, the survey should train
observers to recognize them to increase specificity.
In addition, our recommendations for validation stu-
dies of field instruments for diagnosis of eczema are
that:
1. The time between field testing and validation be as
short as possible.
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2. The period over which eczema is diagnosed (point
prevalence, one-year prevalence etc.) be the same for
the field instrument and the gold standard.
3. Doctors used as the gold standard be as blind as
possible to the field criteria.
4. Examine in detail false negatives and false positives
to identify local obstacles to validity.
Finally, we believe that it is very important to continue
to accumulate evidence on the potential limitations of
the use of field instruments for the diagnosis of eczema
and relevant solutions, and suggest that all studies using
UKWP or ISAAC for research should include a valida-
tion arm.
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